Cva Family Office, LLC 10x Genomics, Inc. Transaction History
Cva Family Office, LLC
- $619 Million
- Q4 2024
A detailed history of Cva Family Office, LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Cva Family Office, LLC holds 5 shares of TXG stock, worth $81. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5
Previous 38
86.84%
Holding current value
$81
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding TXG
# of Institutions
292Shares Held
96.6MCall Options Held
263KPut Options Held
85.1K-
Vanguard Group Inc Valley Forge, PA11MShares$179 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.8MShares$175 Million2.31% of portfolio
-
Morgan Stanley New York, NY6.48MShares$106 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$104 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.6.37MShares$104 Million1.67% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $1.55B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...